Please login to the form below

Not currently logged in
Email:
Password:

Alliance Pharma appoints two European country managers

Dr Philippe Pasdelou and Lars Börger join the UK-based specialty pharma firm

UK specialty company Alliance Pharma has appointed two new country managers.

Dr Philippe Pasdelou will manage operations in France, while Lars Börger will lead the company's teams in Germany, Switzerland and Austria.

At the same time the company announced its acquisition of three antimalarial drugs from AstraZeneca for £4.2m and up to £1m in future sales royalties.

The brands – Paludrine, Avoclor and Savarine – are sold predominately in the UK and France and are expected to generate approximately £1.1m per year to Alliance's balance sheet.

“We are delighted to add these important antimalarial brands to the Alliance portfolio, and at the same time to have appointed such highly experienced executives as Philippe Pasdelou and Lars Börger to spearhead our expansion in mainland Europe,” said John Dawson, chief executive of Alliance Pharma.

The company said both Pasdelou and Börger would initially focus on securing acquisition and in-licensing opportunities across Europe.

Börger was most recently licensing director at Grünenthal and has experience across a number of pharmaceutical and medical device companies, in both strategic and operational roles.

Meanwhile, Pasdelou has managed several pharmaceutical companies in France and other countries and his experience includes setting up a company with a similar business model to Alliance.

14th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics